chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A physician reports post vaccine pt developed fever as high as 102F. Pt also developed 2 episodes of diarrhea, vomited once and developed macular rash on her extremities.
He took the Moderna COVID vaccine all 5 doses and the only side effect was headache; He had COVID on Dec 29; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (He had COVID on Dec 29) and HEADACHE (He took the Moderna COVID vaccine all 5 doses and the only side effect was headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination.    Co-suspect product included non-company product DUPILUMAB (DUPIXENT) for Asthma and Nasal polyps.    The patient's past medical history included Stent placement (2 Stents implanted). Concurrent medical conditions included Rhinitis, Heart attack (2 Stents implanted) since 2016, Pulmonary embolism since 2019, Asthma, Nasal polyps, Blood pressure high (Controlled, recovering.), Factor V Leiden mutation, Difficulty breathing (Issues with breathing) and Condition aggravated (Last couple of years, he had increased flare ups). Concomitant products included RIVAROXABAN (XARELTO) for Factor V Leiden mutation.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and DUPILUMAB (DUPIXENT) (unknown route) 1 dosage form. On 29-Dec-2022, the patient experienced COVID-19 (He had COVID on Dec 29). On an unknown date, the patient experienced HEADACHE (He took the Moderna COVID vaccine all 5 doses and the only side effect was headache). At the time of the report, COVID-19 (He had COVID on Dec 29) and HEADACHE (He took the Moderna COVID vaccine all 5 doses and the only side effect was headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2022, SARS-CoV-2 test: Positive. On an unknown date, Blood pressure measurement: High. On an unknown date, Eosinophil count: Several points higher than normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had bouts of good and bad with the conditions. He was vaccinated and did well with COVID-19 in Dec-2022.   Treatment information was not reported.
Patient experienced fatigue, and was not able to sleep the night of the vaccination;  Arms and back were sore.  This morning when patient woke up,  legs were  sensitive and scratchy. Patient took aleve this morning
Pt reports having low grade temp and chills, stiff neck and pain in both arms.  He started with chest pain later in the evening.  cChest pain started as intermittent. Chest pain became more constant so he went to ER on 2/12 and was admitted until 2/13 and started on Indomethacin
Patient receive J&J vaccine on 3/1/21, two weeks following vaccine patient noted bilateral leg weakness, bilateral LE parasthesias, and bilateral hand parasthesias. Patient admitted to Hospital on 4/5 with 2 weeks of symptoms.  Evaluted by Neurology and underwent MRI Brain, Cervical, Thoracic and Lumbar spine.  Patient underwent Lumbar puncture on 4/7/21.  CSF results revealed Protein 46.9, glucose 69, WBC 1, RBC 1.   Etiology of symptoms with mild elevated protein were concerning for Guillen Barre Syndrome (GBS).
Severe headaches, dizziness, behavorial disorientation, short term memory loss, cognitive processing. Vaccination was Hepatitis B, unknown manufacturer or lot #.
pt slept for 4 1/2hrs p/shot was alert on arouse & not cranky, spiked t104? p/vax;given APAP & luke warm water sponging initially w/o response changed to Motrin temp dec to 99 & remained so for following 24hrs
This spontaneous report as received from a pharmacist refers to a 62 years old male patient with asthma. The patient was vaccinated with ZOSTAVAX (lot# unspecified) on 04-JUL-2012 ("one week ago"). No concomitant medications were reported. In 2012 the patient had a asthma exacerbation. The pharmacist didn't think the patient's symptoms were related to the ZOSTAVAX. The patient brought prescriptions to the pharmacy for MEDROL, ipratropium bromide, albuterol, SPIRIVA and DULERA. Pharmacist said the ZOSTAVAX was administered at a different Pharmacy. No treatment information was reported. The outcome of asthma exacerbation was unknown. The patient had sought medical attention via office visit. Additional information has been requested.
Sore left arm, swollen and red around injection site, slight fever, muscle aches, nausea, dizziness
Patient received second dose of moderna vaccine 0.25mL; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received second dose of moderna vaccine 0.25mL) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No known allergies to medications, food and other products were reported.  Concurrent medical conditions included Iron deficiency and Chronic kidney disease stage 3 (Stage 3B Chronic Kidney Disease) since 2021.    On 27-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021, the patient experienced ACCIDENTAL UNDERDOSE (Patient received second dose of moderna vaccine 0.25mL). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received second dose of moderna vaccine 0.25mL) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment medications were not provided.   This case was linked to MOD-2022-573301 (Patient Link).
This is a spontaneous report received from a contactable reporter Consumer. The reporter is the parent. A 39 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 11Apr2021 (Lot number: EW0158, Expiration Date: 31Jul2021) at the age of 39 years as dose 1, single for Covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), BACK PAIN (non-serious) all with onset 12Apr2021, outcome "unknown" and all described as "aching in legs and back". Therapeutic measures were taken as a result of pain in extremity, back pain as he started taking Advil. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No follow-up attempts are possible. No further information is expected.
I was wondering i went past my 2nd vaccine date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I was wondering i went past my 2nd vaccine date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I was wondering i went past my 2nd vaccine date). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I was wondering i went past my 2nd vaccine date) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Began night of vaccine, arm was warm , woke up 05/18/2021  L arm was in pain and hot... , later that night he felt nausea.. chest tightening , SOB , pain was intermittent and becoming progressively worse. 05/19/2021 - Underneath his L arm the swelling has increased, with pain and warm. Chest tightness and SOB is intermittent.
Irregular menses 4 weeks following dose, bleeding irregular in timing/frequency and quantity.   Heavy vaginal bleeding two weeks following dose, off cycle from normal menses, followed by very light bleeding during ?usual? cycle
Flu shot administered at 12:30 - at 5:30 developed chills, red eyes, sore throat and vomited 3 times.
Information has been received from a certified medical assistant assistant and a physician concerning a female with acne and a history of urticaria (2004 unknown cause) who in February 2007 ("about 3 weeks ago"), was vaccinated IM with Gardasil. Concomitant therapy included unspecified antibiotic. Within a week the patient experienced urticaria, itchiness, low grade fever (100 F) and soreness. Subsequently, the patient recovered from urticaria, itchiness, low grade fever 100f and soreness. The patient sought unspecified medical attention. Additional information has been requested.
Fever; Arm felt like tetanus arm pain, it was just tender to touch it; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (Fever) and VACCINATION SITE PAIN (Arm felt like tetanus arm pain, it was just tender to touch it) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced PYREXIA (Fever) and VACCINATION SITE PAIN (Arm felt like tetanus arm pain, it was just tender to touch it). At the time of the report, PYREXIA (Fever) and VACCINATION SITE PAIN (Arm felt like tetanus arm pain, it was just tender to touch it) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.   This case was linked to MOD-2021-423217, MOD-2021-423238 (Patient Link).
Pt became listless, then devel high fever 104, treated w/APAP no results; began sz taken by ambulance to Hosp; Exp a total of 13 sz on way to hosp;
Patient here with acute hypoxic respiratory failure, improved with respiratory support via BiPAP.  He is hemodynamically stable, awake and alert.  He patient has voiced clearly to myself and to multiple nursing staff, Members at the bedside that patient would not wish to be intubated and placed on mechanical ventilation should his respiratory status further deteriorate.  Patient had very little oxygen reserve with desaturations very quickly into the high 70s on room air when transitioned from stretcher into bed.  He has no prior history of cardiac or pulmonary disease.  Presentation highly suspicious for COVID-19, which was confirmed with diagnostic testing here today.  Bilateral pneumonia noted on chest XR. Likely viral in nature.  Patient presented to the emergency room at this facility by ambulance which had been summoned to his house by his sister whom happens to be a nurse practitioner.  Apparently the patient had developed upper respiratory symptoms for the last 5 days or so and at his sister had called in the prescription for Zithromax and a Medrol Pak about 3 days ago.  Apparently she went to check on him today and found him cyanotic.  When EMS arrived to assess the patient they found his oxygen saturations to be 55% on room air.  The patient was placed on a non-rebreather and improved to mid 80s and he was then placed on CPAP with improvement to the low 90s.   Upon arrival to the emergency room he was placed on a BiPAP and he has remained stable in terms of oxygenation.  Patient reports receiving 2 doses of Pfizer vaccine.  He reported not being aware of sick contacts.  I had received a call from reading radiologist the reported and small burden of blood clot in the right upper lobe of the lung besides findings compatible with pneumonia.  Patient had also been found to be in atrial fibrillation with moderate ventricular response.
The pt developed autism; did not reach typical milestones. The pt does speak now but not age appropriate and has difficulty understanding all said to him.
Menstrual period began 1 week earlier than normal. I am very regular at 28 days, but started at 21 days. Feeling rapid heartbeat at times. The first one occurred 5 minutes after the injection. I have experienced the rapid heartbeat several times since being vaccinated.
pt reported pain in lt shoulder, aching & dec movement on 8NOV96;stated the inj was given into the joint;advised to see PMD;13NOV6 950AM pt reports aching in arm immed p/vax;seen by MD for pain limited movement of lt arm;
Bilateral optic neuritis; Myocarditis; This literature-non-study case was reported in a literature article and describes the occurrence of OPTIC NEURITIS (Bilateral optic neuritis) and MYOCARDITIS (Myocarditis) in a 40-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.       No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced OPTIC NEURITIS (Bilateral optic neuritis) (seriousness criterion medically significant) and MYOCARDITIS (Myocarditis) (seriousness criterion medically significant). At the time of the report, OPTIC NEURITIS (Bilateral optic neuritis) and MYOCARDITIS (Myocarditis) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported.  In this report author presented a case of myocarditis and bilateral optic neuritis that occurred in a young healthy patient after the administration of first dose of mRNA-1273 vaccine (Moderna).  Company Comment: This is a literature non-study case concerning a 40-year-old, male patient with no reported medical history, who experienced the serious (due to medically significant) expected AESI Myocarditis and the unexpected serious (due to medically significant) AESI optic neuritis.  The event occurred after receiving the first dose of mRNA-1273 vaccine (date not provided). No concomitant and treatment medications were reported. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Janssen booster on 2-18-2022 around 3:30 PM. Early the following morning (2-19-2022 around 2 am), I woke up with fever, chills, severe lower back pain, severe hip pain, and headache. The back and hip pain was so severe I could not even walk down our stairs to reach the kitchen. Symptoms persisted throughout the day of 2-19-2022. Symptoms resolved on 2-20-2022, except the severe lower back and hip pain. Today is 3-2-2022, and the lower back and hip pain is still present, approximately 5 out of 10 on pain scale. No hip or back issues prior to receiving the Janssen vaccine.
pt claims that was dx w/trigeminal neuropathy around thanksgiving time 1996;pt only mentioned this today 12MAY97;
I am currently 9 weeks and 4 days pregnant. I am due July 17th, 2022. My adverse side effect is an itchy rash on my left wrist and on the inner elbow on my right arm.
ACUTE NON ST ELEVATION MI ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 2 MI (SUPPLY/DEMAND) HYPOTENSION ACUTE PULMONARY EMBOLISM
swelling of her feet; she broke out in 3 different rashes 2 days after getting the 2nd vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of her feet) and RASH (she broke out in 3 different rashes 2 days after getting the 2nd vaccine) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling of her feet) and RASH (she broke out in 3 different rashes 2 days after getting the 2nd vaccine). The patient was treated with TRIAMCINOLONE (topical) ongoing from 05-Mar-2021 at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (swelling of her feet) and RASH (she broke out in 3 different rashes 2 days after getting the 2nd vaccine) had not resolved.            Patient stated she was having a lot of problems since having the 2nd vaccine. Patient stated that she  broke out in 3 different places 2 days after getting the 2nd vaccine. Patient stated that  rashes were  all on her left side including her face. Patient also reported swelling of her feet. Patient stated her right side had rash as well, but it was not as bad as the left. Patient stated that she went to see a dermatologist who initially gave her some samples of ointment to use and when she returned 2 weeks later, he prescribed more creams to apply.   No concomitant medication information was provided.   This case was linked to MOD-2021-033010 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received and two dose details were added , patient demographics, treatment medication and event outcome was updated.
11:08 Text from client's mom:  allergic reaction, throat swelling and hives all over.  Client took Benadryl.  Instructed to go to ER and ask them to complete a VAERS form.   The mom texted  back,: he took some Benadryl and it was about 30 minutes and he could feel things staring to go down and he feels a ton better, so I think we are OK. At 1:02 PM  I texted her "How is he doing?"  Her reply: "Much Better." At 5:11 PM Client's mom called and said patient was having chest congestion, swelling in his throat and sick to his stomach and nausea.  I instructed her once again to get him to the ER .  Client took Benadryl once again and also went to the ER.   At 6:36 PM Client's mom let me know they were giving him an epinephrine shot and a steroid shot. she also texted:  Dr. has never seen this kind of reaction.   6/3/2021 9:30 AM   Client "so much better, thank goodness.   6/8/2021  Client himself stated he was fine.  No additional problems
This spontaneous report as received from a Nurse refers to 21 patients of unknown demography. On an unknown date, the 21 patients were vaccinated with one dose of improperly stored VARIVAX (lot # L034372, lot # M006722 and lot # M006731) subcutaneous (incorrect product storage). The Nurse reported that the VARIVAX underwent a temperature excursion prior being administration to the patients. The maximum temperature was 18.4F for 1 hour 47 minutes and time frame and date of excursion was unknown by the reporter. No known adverse effects were reported. No further information was provided. No PQC involved. Additional information has been requested.
Immediate blurred vision; nausea; sweats; This is a spontaneous report from a non-contactable consumer (patient). A 12-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration, administered in left arm on 20May2021 at 10:00 at the age of 12-years-old as dose number unknown, single for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 10:00, the patient experienced immediate blurred vision, nausea and sweats. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events, immediate blurred vision, nausea and sweats were recovering at the time of this report.   The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow up.
pain in site, and in forearm, that also happened when vaccine was injected; pain in site, and in forearm, that also happened when vaccine was injected; chills; fever; congestion; achy; This is a spontaneous report from a non-contactable other health care professional (nurse). A female patient of a 68 (units unknown) age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported, Expiry date: not reported), dose 1 via an unspecified route of administration, administered at unspecified anatomical location on 19Mar2021 (age at vaccination was 68 (units unknown) as dose 1, single for COVID-19 immunization. Medical history included shortness of breath. The patient concomitant medications were not reported. In Mar2021, The patient experienced chills, fever, congestion. On 19Mar2021, patient also experienced pain in site, and in forearm, that also happened when vaccine was injected. on an unspecified date, experienced achy. The patient stated that she did not take any medications and suspected that she may have had covid 3 or 4 months before it hit her region, but no testing was done, so she never had a PCR test. The patient may be a little bit of long hauler with ongoing symptoms. The patient had shortness of breath with the virus but haven't taken pulse ox in a while. The patient major concern is because she had 18 hours of achy, chills, after the first dose, and thinking, this may be a little bit more information toward (or indicating) that she did have it last year. The patient plan was to wait two weeks and donate blood. to decrease her volume by 10 % and a week later when she has a chance to recoup get the second dose, hoping that it may lessen the response from the second dose. Long haulers from the virus have not found a good way to alleviate those symptoms, they try, vitamin C, NAC, heat, ice. A couple of issues to help with symptoms, but not working much. There are people who have had the virus that respond to the first dose and respond to the second dose with a spiking temp and getting symptoms again, and then it clears, and their energy comes back, they don't experience as much shortness of breath and there is a lifting of brain fog, they basically feel 80 % back to normal. The patient wanted to know whether she can donate blood, if she chooses to donate blood tomorrow she should have some antibodies, it's good for them they get a unit of blood and a unit of blood with antibodies. The patient was wondering if by donating blood would it lessen the effects of the second dose. The (institution name) says if you are 3 days away from the injection you are good to donate. The patient wanted to know whether she can be in clinical trial. Where she one of population in 1.5 million people, only 300,000 have registered for the vaccine. The outcome of chills, fever, congestion, vaccination site pain, pain was unknown and outcome of pain in extremity was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore arm. Fatigue. Headache. Sleeplessness. Achy.
Very enlarged suprascapular lymph nodes, vomiting x2 days, extreme lethargy/fatigue but unable to sleep, insomnia, dizziness x2 days, lightheaded/nauseous x3 days.